{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:52:36Z","timestamp":1785826356213,"version":"3.56.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009934","name":"E\u00f6tv\u00f6s Lor\u00e1nd University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009934","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Trace Elem Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Copper bioavailability has been identified as a potential target for KRAS-mutant colorectal cancer, a disease for which treatment options remain limited. Therefore, we investigated copper homeostasis in isogeneic colorectal cancer cell models carrying distinct KRAS codon 12 mutations (G12C, G12D and G12V). Our results show that copper homeostasis differs among KRAS-mutant cells in a mutation-specific manner, with the greatest change observed in G12V, followed by G12C and then G12D. Specifically, G12V-mutant cells show reduced copper levels, increased copper uptake, reduced intracellular copper levels after prolonged exposure to exogenous copper, reduced sensitivity to copper-induced toxicity, protection against intracellular copper chelators (neocuproine, DpC, Dp44mT), and increased expression of the copper transporter ATP7A. In contrast, G12D mutant cells exhibit minimal differences in copper metabolism compared to controls, while G12C display an intermediate phenotype between the other two mutations. Notably, the copper chelator ammonium tetrathiomolybdate inhibited cell growth in all KRAS-mutant cells. Our results suggest that KRAS-mutant colorectal cancer cells are sensitive to perturbations in copper homeostasis in a mutation subtype-specific manner.<\/jats:p>","DOI":"10.1007\/s12011-026-05171-w","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:42:00Z","timestamp":1780414920000},"page":"7038-7053","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Subtype-Specific Alterations in Copper Trafficking Associated with KRAS Mutations in Isogenic Colorectal Cancer Cell Lines"],"prefix":"10.1007","volume":"204","author":[{"given":"Elina","family":"\u00dcveges","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anik\u00f3","family":"Ga\u00e1l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergely","family":"Szak\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9va","family":"Bakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Streli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kregsamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcell","family":"Baranyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs","family":"Heged\u0171s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Szoboszlai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"5171_CR1","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1158\/0008-5472.CAN-19-3682","volume":"80","author":"IA Prior","year":"2020","unstructured":"Prior IA, Hood FE, Hartley JL (2020) The frequency of Ras mutations in cancer. Cancer Res 80:2969\u20132974. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-3682","journal-title":"Cancer Res"},{"key":"5171_CR2","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s10555-020-09915-5","volume":"39","author":"J Timar","year":"2020","unstructured":"Timar J, Kashofer K (2020) Molecular epidemiology and diagnostics of KRAS mutations in human cancer. Cancer Metastasis Rev 39:1029\u20131038. https:\/\/doi.org\/10.1007\/s10555-020-09915-5","journal-title":"Cancer Metastasis Rev"},{"key":"5171_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cells10030667","volume":"10","author":"L L\u00e1szl\u00f3","year":"2021","unstructured":"L\u00e1szl\u00f3 L, Kurilla A, Tak\u00e1cs T et al (2021) Recent updates on the significance of KRAS mutations in colorectal cancer biology. Cells 10:667","journal-title":"Cells"},{"key":"5171_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/srep39721","volume":"7","author":"Z Lohinai","year":"2017","unstructured":"Lohinai Z, Klikovits T, Moldvay J et al (2017) KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis. Sci Rep 7:39721. https:\/\/doi.org\/10.1038\/srep39721","journal-title":"Sci Rep"},{"key":"5171_CR5","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1056\/NEJMoa2103695","volume":"384","author":"F Skoulidis","year":"2021","unstructured":"Skoulidis F, Li BT, Dy GK et al (2021) Sotorasib for lung cancers with KRAS p.G12C mutation. N Engl J Med 384:2371\u20132381. https:\/\/doi.org\/10.1056\/NEJMoa2103695","journal-title":"N Engl J Med"},{"key":"5171_CR6","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2204619","volume":"387","author":"PA J\u00e4nne","year":"2022","unstructured":"J\u00e4nne PA, Riely GJ, Gadgeel SM et al (2022) Adagrasib in non\u2013small-cell lung cancer harboring a KRASG12C mutation. N Engl J Med 387:120\u2013131. https:\/\/doi.org\/10.1056\/NEJMoa2204619","journal-title":"N Engl J Med"},{"key":"5171_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1056\/NEJMoa2212419","volume":"388","author":"R Yaeger","year":"2023","unstructured":"Yaeger R, Weiss J, Pelster MS et al (2023) Adagrasib with or without Cetuximab in colorectal cancer with mutated KRAS G12C. N Engl J Med 388:44\u201354. https:\/\/doi.org\/10.1056\/NEJMoa2212419","journal-title":"N Engl J Med"},{"key":"5171_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00780-4","volume":"6","author":"L Huang","year":"2021","unstructured":"Huang L, Guo Z, Wang F, Fu L (2021) KRAS mutation: from undruggable to druggable in cancer. Signal Transduct Target Ther 6:386. https:\/\/doi.org\/10.1038\/s41392-021-00780-4","journal-title":"Signal Transduct Target Ther"},{"key":"5171_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17549-y","volume":"11","author":"L Aubert","year":"2020","unstructured":"Aubert L, Nandagopal N, Steinhart Z et al (2020) Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer. Nat Commun 11:3701. https:\/\/doi.org\/10.1038\/s41467-020-17549-y","journal-title":"Nat Commun"},{"key":"5171_CR10","doi-asserted-by":"publisher","first-page":"18285","DOI":"10.1073\/pnas.1904610116","volume":"116","author":"CY-S Chung","year":"2019","unstructured":"Chung CY-S, Posimo JM, Lee S et al (2019) Activity-based ratiometric FRET probe reveals oncogene-driven changes in labile copper pools induced by altered glutathione metabolism. Proc Natl Acad Sci U S A 116:18285\u201318294. https:\/\/doi.org\/10.1073\/pnas.1904610116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5171_CR11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2202736119","volume":"119","author":"AT Pezacki","year":"2022","unstructured":"Pezacki AT, Matier CD, Gu X et al (2022) Oxidation state-specific fluorescent copper sensors reveal oncogene-driven redox changes that regulate labile copper(II) pools. Proc Natl Acad Sci U S A 119:e2202736119. https:\/\/doi.org\/10.1073\/pnas.2202736119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5171_CR12","doi-asserted-by":"publisher","DOI":"10.1080\/23723556.2020.1822123","author":"L Aubert","year":"2020","unstructured":"Aubert L, Nandagopal N, Roux PP (2020) Targeting copper metabolism to defeat KRAS-driven colorectal cancer. Mol Cell Oncol. https:\/\/doi.org\/10.1080\/23723556.2020.1822123","journal-title":"Mol Cell Oncol"},{"key":"5171_CR13","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1039\/c5mt00097a","volume":"7","author":"C Lin","year":"2015","unstructured":"Lin C, Zhang Z, Wang T et al (2015) Copper uptake by DMT1: a compensatory mechanism for CTR1 deficiency in human umbilical vein endothelial cells\u2020. Metallomics 7:1285\u20131289. https:\/\/doi.org\/10.1039\/c5mt00097a","journal-title":"Metallomics"},{"key":"5171_CR14","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.7150\/thno.67889","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H, Qian F (2022) Exploiting macropinocytosis for drug delivery into KRAS mutant cancer. Theranostics 12:1321\u20131332. https:\/\/doi.org\/10.7150\/thno.67889","journal-title":"Theranostics"},{"key":"5171_CR15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/mt.2015.164","volume":"24","author":"X Chen","year":"2016","unstructured":"Chen X, Gon\u00e7alves MAFV (2016) Engineered viruses as genome editing devices. Mol Ther 24:447\u2013457. https:\/\/doi.org\/10.1038\/mt.2015.164","journal-title":"Mol Ther"},{"key":"5171_CR16","doi-asserted-by":"crossref","unstructured":"16. Polg\u00e1ri Z, Ajtony Z, Kregsamer P et al (2011) Microanalytical method development for Fe, Cu and Zn determination in colorectal cancer cells. Talanta 85:1959\u20131965","DOI":"10.1016\/j.talanta.2011.07.015"},{"key":"5171_CR17","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/s10534-025-00736-z","volume":"38","author":"A Ga\u00e1l","year":"2025","unstructured":"Ga\u00e1l A, Torma L, Bakos \u00c9 et al (2025) ABCC1 promotes GSH-dependent iron transport and resistance to Fe(II) and Cu(II) chelators. Biometals 38:1881\u20131895. https:\/\/doi.org\/10.1007\/s10534-025-00736-z","journal-title":"Biometals"},{"key":"5171_CR18","doi-asserted-by":"crossref","unstructured":"Waterborg JH (2009) The Lowry Method for Protein Quantitation. In: Walker JM (ed) The Protein Protocols Handbook. Humana Press, Totowa, NJ, pp 7\u201310","DOI":"10.1007\/978-1-59745-198-7_2"},{"key":"5171_CR19","doi-asserted-by":"crossref","unstructured":"Gwozdz T, Dorey K (2017) Chap.\u00a06 - Western Blot. In: Jalali M, Saldanha FYL, Jalali M (eds) Basic Science Methods for Clinical Researchers. Academic Press, Boston, pp 99\u2013117","DOI":"10.1016\/B978-0-12-803077-6.00006-0"},{"key":"5171_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-020-01674-2","volume":"16","author":"D Varshavi","year":"2020","unstructured":"Varshavi D, Varshavi D, McCarthy N et al (2020) Metabolic characterization of colorectal cancer cells harbouring different KRAS mutations in codon 12, 13, 61 and 146 using human SW48 isogenic cell lines. Metabolomics 16:51. https:\/\/doi.org\/10.1007\/s11306-020-01674-2","journal-title":"Metabolomics"},{"key":"5171_CR21","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s12094-023-03107-7","volume":"25","author":"Z Jiang","year":"2023","unstructured":"Jiang Z, Sha G, Zhang W et al (2023) The huge potential of targeting copper status in the treatment of colorectal cancer. Clin Transl Oncol 25:1977\u20131990. https:\/\/doi.org\/10.1007\/s12094-023-03107-7","journal-title":"Clin Transl Oncol"},{"key":"5171_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10534-024-00660-8","volume":"38","author":"AV Skalny","year":"2025","unstructured":"Skalny AV, Kushlinskii NE, Korobeinikova TV et al (2025) Zinc, copper, copper-to-zinc ratio, and other biometals in blood serum and tumor tissue of patients with colorectal cancer. Biometals 38:529\u2013544. https:\/\/doi.org\/10.1007\/s10534-024-00660-8","journal-title":"Biometals"},{"key":"5171_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2024.127564","volume":"86","author":"K Hari","year":"2024","unstructured":"Hari K, Squitti R, Bosco J et al (2024) Classification of colorectal cancer patients based on serum micronutrients: an exploratory investigation. J Trace Elem Med Biol 86:127564. https:\/\/doi.org\/10.1016\/j.jtemb.2024.127564","journal-title":"J Trace Elem Med Biol"},{"key":"5171_CR24","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.1007\/s12011-024-04440-w","volume":"203","author":"R Squitti","year":"2025","unstructured":"Squitti R, Tondolo V, Pal A et al (2025) Copper Dysmetabolism is Connected to Epithelial-Mesenchymal Transition: A Pilot Study in Colorectal Cancer Patients. Biological Trace Element Research 203:3604\u20133617. https:\/\/doi.org\/10.1007\/s12011-024-04440-w","journal-title":"Biological Trace Element Research"},{"key":"5171_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9080852","volume":"9","author":"MV Babak","year":"2021","unstructured":"Babak MV, Ahn D (2021) Modulation of intracellular copper levels as the mechanism of action of anticancer copper complexes: clinical relevance. Biomedicines 9:852","journal-title":"Biomedicines"},{"key":"5171_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ctrv.2008.07.004","volume":"35","author":"A Gupte","year":"2009","unstructured":"Gupte A, Mumper RJ (2009) Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. Cancer Treat Rev 35:32\u201346. https:\/\/doi.org\/10.1016\/j.ctrv.2008.07.004","journal-title":"Cancer Treat Rev"},{"key":"5171_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jtemb.2018.01.011","volume":"47","author":"A Ga\u00e1l","year":"2018","unstructured":"Ga\u00e1l A, Orgov\u00e1n G, Mihucz VG et al (2018) Metal transport capabilities of anticancer copper chelators. J Trace Elem Med Biol 47:79\u201388. https:\/\/doi.org\/10.1016\/j.jtemb.2018.01.011","journal-title":"J Trace Elem Med Biol"},{"key":"5171_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103971","volume":"89","author":"R Pandey","year":"2026","unstructured":"Pandey R, Roy AN, Sarkar S et al (2026) Repurposing melatonin\u2019s therapeutic potential in Wilson disease: Addressing copper overload and redox imbalance. Redox Biology 89:103971. https:\/\/doi.org\/10.1016\/j.redox.2025.103971","journal-title":"Redox Biology"},{"key":"5171_CR29","doi-asserted-by":"publisher","first-page":"C588","DOI":"10.1152\/ajpcell.00054.2010","volume":"300","author":"AM Zimnicka","year":"2011","unstructured":"Zimnicka AM, Ivy K, Kaplan JH (2011) Acquisition of dietary copper: a role for anion transporters in intestinal apical copper uptake. Am J Physiol Cell Physiol 300:C588\u2013C599. https:\/\/doi.org\/10.1152\/ajpcell.00054.2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"5171_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2024.100625","volume":"5","author":"B Gy\u0151rffy","year":"2024","unstructured":"Gy\u0151rffy B (2024) Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innovation 5:100625. https:\/\/doi.org\/10.1016\/j.xinn.2024.100625","journal-title":"Innovation"},{"key":"5171_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2023.09.295","volume":"18","author":"J Zhao","year":"2023","unstructured":"Zhao J, Zeng Y, Wang A et al (2023) P1.02-04 Targeting ATP7A by Elesclomol-Copper derived endoplasmic reticulum stress to mediate cuproptosis in KRAS-G12 mutant LUAD. J Thorac Oncol 18:S189. https:\/\/doi.org\/10.1016\/j.jtho.2023.09.295","journal-title":"J Thorac Oncol"},{"key":"5171_CR32","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature11252","volume":"487","author":"DM Muzny","year":"2012","unstructured":"Muzny DM, Bainbridge MN, Chang K et al (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487:330\u2013337. https:\/\/doi.org\/10.1038\/nature11252","journal-title":"Nature"},{"key":"5171_CR33","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41556-020-0481-4","volume":"22","author":"T Tsang","year":"2020","unstructured":"Tsang T, Posimo JM, Gudiel AA et al (2020) Copper is an essential regulator of the autophagic kinases ULK1\/2 to drive lung adenocarcinoma. Nat Cell Biol 22:412\u2013424. https:\/\/doi.org\/10.1038\/s41556-020-0481-4","journal-title":"Nat Cell Biol"},{"key":"5171_CR34","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1158\/1541-7786.MCR-22-0056","volume":"20","author":"Y Su","year":"2022","unstructured":"Su Y, Zhang X, Li S et al (2022) Emerging roles of the copper\u2013CTR1 axis in tumorigenesis. Mol Cancer Res 20:1339\u20131353. https:\/\/doi.org\/10.1158\/1541-7786.MCR-22-0056","journal-title":"Mol Cancer Res"},{"key":"5171_CR35","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nature12138","volume":"497","author":"C Commisso","year":"2013","unstructured":"Commisso C, Davidson SM, Soydaner-Azeloglu RG et al (2013) Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature 497:633\u2013637. https:\/\/doi.org\/10.1038\/nature12138","journal-title":"Nature"},{"key":"5171_CR36","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.tcb.2014.06.001","volume":"24","author":"D Ackerman","year":"2014","unstructured":"Ackerman D, Simon MC (2014) Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment. Trends Cell Biol 24:472\u2013478. https:\/\/doi.org\/10.1016\/j.tcb.2014.06.001","journal-title":"Trends Cell Biol"},{"key":"5171_CR37","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1042\/bj20031174","volume":"378","author":"L Tapia","year":"2004","unstructured":"Tapia L, Gonz\u00e1lez-Ag\u00fcero M, Cisternas MF et al (2004) Metallothionein is crucial for safe intracellular copper storage and cell survival at normal and supra-physiological exposure levels. Biochem J 378:617\u2013624. https:\/\/doi.org\/10.1042\/bj20031174","journal-title":"Biochem J"},{"key":"5171_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/antiox5030025","author":"Y Hatori","year":"2016","unstructured":"Hatori Y, Lutsenko S (2016) The role of copper chaperone Atox1 in coupling redox homeostasis to intracellular copper distribution. Antioxidants. https:\/\/doi.org\/10.3390\/antiox5030025","journal-title":"Antioxidants"},{"key":"5171_CR39","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41571-024-00876-0","volume":"21","author":"D Tang","year":"2024","unstructured":"Tang D, Kroemer G, Kang R (2024) Targeting cuproplasia and cuproptosis in cancer. Nat Rev Clin Oncol 21:370\u2013388. https:\/\/doi.org\/10.1038\/s41571-024-00876-0","journal-title":"Nat Rev Clin Oncol"},{"key":"5171_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-024-00608-3","volume":"29","author":"L Li","year":"2024","unstructured":"Li L, Zhou H, Zhang C (2024) Cuproptosis in cancer: biological implications and therapeutic opportunities. Cell Mol Biol Lett 29:91. https:\/\/doi.org\/10.1186\/s11658-024-00608-3","journal-title":"Cell Mol Biol Lett"},{"key":"5171_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-04263-z","author":"H Wang","year":"2025","unstructured":"Wang H, Yang Y, Du J (2025) Cuproptosis: the mechanisms of copper-induced cell death and its implication in colorectal cancer. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-025-04263-z","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5171_CR42","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.microc.2016.12.007","volume":"136","author":"A Ga\u00e1l","year":"2018","unstructured":"Ga\u00e1l A, Mihucz VG, B\u0151sze S et al (2018) Comparative in vitro investigation of anticancer copper chelating agents. Microchem J 136:227\u2013235. https:\/\/doi.org\/10.1016\/j.microc.2016.12.007","journal-title":"Microchem J"},{"key":"5171_CR43","doi-asserted-by":"crossref","unstructured":"Ga\u00e1l A, Orgov\u00e1n G, Polg\u00e1ri Z, et al (2014) Complex forming competition and in-vitro toxicity studies on the applicability of di-2-pyridylketone-4, 4,-dimethyl-3-thiosemicarbazone (Dp44mT) as a metal chelator. Journal of inorganic biochemistry 130:52\u201358","DOI":"10.1016\/j.jinorgbio.2013.09.016"},{"key":"5171_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115444","author":"K Budagyan","year":"2025","unstructured":"Budagyan K, Cannon AC, Chatoff A et al (2025) KRAS G12V mutation-selective requirement for ACSS2 in colorectal adenoma formation. Cell Rep. https:\/\/doi.org\/10.1016\/j.celrep.2025.115444","journal-title":"Cell Rep"},{"key":"5171_CR45","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/bjc.2017.37","volume":"116","author":"RP Jones","year":"2017","unstructured":"Jones RP, Sutton PA, Evans JP et al (2017) Specific mutations in KRAS codon 12 are associated with worse overall survival in patients with advanced and recurrent colorectal cancer. Br J Cancer 116:923\u2013929. https:\/\/doi.org\/10.1038\/bjc.2017.37","journal-title":"Br J Cancer"},{"key":"5171_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14143320","author":"A Koulouridi","year":"2022","unstructured":"Koulouridi A, Karagianni M, Messaritakis I et al (2022) Prognostic Value of KRAS Mutations in Colorectal Cancer Patients. Cancers. https:\/\/doi.org\/10.3390\/cancers14143320","journal-title":"Cancers"},{"key":"5171_CR47","doi-asserted-by":"publisher","first-page":"40253","DOI":"10.1074\/jbc.M208002200","volume":"277","author":"J Lee","year":"2002","unstructured":"Lee J, Petris MJ, Thiele DJ (2002) Characterization of Mouse Embryonic Cells Deficient in the Ctr1 High Affinity Copper Transporter: IDENTIFICATION OF A Ctr1-INDEPENDENT COPPER TRANSPORT SYSTEM *. J Biol Chem 277:40253\u201340259. https:\/\/doi.org\/10.1074\/jbc.M208002200","journal-title":"J Biol Chem"},{"key":"5171_CR48","doi-asserted-by":"publisher","first-page":"C768","DOI":"10.1152\/ajpcell.00417.2012","volume":"304","author":"EB Maryon","year":"2013","unstructured":"Maryon EB, Molloy SA, Kaplan JH (2013) Cellular glutathione plays a key role in copper uptake mediated by human copper transporter 1. Am J Physiol Cell Physiol 304:C768\u2013C779. https:\/\/doi.org\/10.1152\/ajpcell.00417.2012","journal-title":"Am J Physiol Cell Physiol"},{"key":"5171_CR49","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1158\/0008-5472.CAN-22-2125","volume":"82","author":"R Nussinov","year":"2022","unstructured":"Nussinov R, Tsai CJ, Jang H (2022) A New View of Activating Mutations in Cancer. Cancer Res 82:4114\u20134123. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-2125","journal-title":"Cancer Res"},{"key":"5171_CR50","doi-asserted-by":"publisher","unstructured":"Ihle NT, Byers LA, Kim ES, et al (2012) Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome. JNCI: Journal of the National Cancer Institute 104:228\u2013239. https:\/\/doi.org\/10.1093\/jnci\/djr523","DOI":"10.1093\/jnci\/djr523"},{"key":"5171_CR51","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1093\/carcin\/bgl063","volume":"27","author":"M Cespedes","year":"2006","unstructured":"Cespedes M, Sancho F, Guerrero S et al (2006) K-ras Asp12 mutant neither interacts with Raf, nor signals through Erk and is less tumorigenic than K-ras Val12. Carcinogenesis 27:2190\u2013200. https:\/\/doi.org\/10.1093\/carcin\/bgl063","journal-title":"Carcinogenesis"},{"key":"5171_CR52","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cell.2017.06.009","volume":"170","author":"DK Simanshu","year":"2017","unstructured":"Simanshu DK, Nissley DV, McCormick F (2017) RAS Proteins and Their Regulators in Human Disease. Cell 170:17\u201333. https:\/\/doi.org\/10.1016\/j.cell.2017.06.009","journal-title":"Cell"},{"key":"5171_CR53","doi-asserted-by":"publisher","first-page":"10402","DOI":"10.1073\/pnas.1903506116","volume":"116","author":"N Tejeda-Mu\u00f1oz","year":"2019","unstructured":"Tejeda-Mu\u00f1oz N, Albrecht LV, Bui MH, Robertis EMD (2019) Wnt canonical pathway activates macropinocytosis and lysosomal degradation of extracellular proteins. Proc Natl Acad Sci U S A 116:10402\u201310411. https:\/\/doi.org\/10.1073\/pnas.1903506116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5171_CR54","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/nchem.2381","volume":"7","author":"J Wang","year":"2015","unstructured":"Wang J, Luo C, Shan C et al (2015) Inhibition of human copper trafficking by a small molecule significantly attenuates cancer cell proliferation. Nat Chem 7:968\u2013979. https:\/\/doi.org\/10.1038\/nchem.2381","journal-title":"Nat Chem"},{"key":"5171_CR55","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1001\/archneur.63.4.521","volume":"63","author":"GJ Brewer","year":"2006","unstructured":"Brewer GJ, Askari F, Lorincz MT et al (2006) Treatment of Wilson Disease With Ammonium Tetrathiomolybdate: IV. Comparison of Tetrathiomolybdate and Trientine in a Double-blind Study of Treatment of the Neurologic Presentation of Wilson Disease. Archives of Neurology 63:521\u2013527. https:\/\/doi.org\/10.1001\/archneur.63.4.521","journal-title":"Archives of Neurology"},{"key":"5171_CR56","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/archneur.60.3.379","volume":"60","author":"GJ Brewer","year":"2003","unstructured":"Brewer GJ, Hedera P, Kluin KJ et al (2003) Treatment of Wilson Disease with Ammonium Tetrathiomolybdate: III. initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy. Arch Neurol 60:379\u2013385. https:\/\/doi.org\/10.1001\/archneur.60.3.379","journal-title":"Arch Neurol"},{"key":"5171_CR57","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000438485","volume":"52","author":"E Urso","year":"2015","unstructured":"Urso E, Maffia M (2015) Behind the link between copper and angiogenesis: established mechanisms and an overview on the role of vascular copper transport systems. J Vasc Res 52:172\u2013196. https:\/\/doi.org\/10.1159\/000438485","journal-title":"J Vasc Res"},{"key":"5171_CR58","doi-asserted-by":"publisher","unstructured":"Chisholm CL, Wang H, Wong AH-H, et al (2016) Ammonium tetrathiomolybdate treatment targets the copper transporter ATP7A and enhances sensitivity of breast cancer to cisplatin. Oncotarget 7:84439\u201384452. https:\/\/doi.org\/10.18632\/oncotarget.12992","DOI":"10.18632\/oncotarget.12992"},{"key":"5171_CR59","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1158\/1078-0432.CCR-16-1326","volume":"23","author":"N Chan","year":"2017","unstructured":"Chan N, Willis A, Kornhauser N et al (2017) Influencing the tumor microenvironment: a phase II study of copper depletion using Tetrathiomolybdate in patients with breast cancer at high risk for recurrence and in preclinical models of lung metastases. Clin Cancer Res 23:666\u2013676. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-1326","journal-title":"Clin Cancer Res"},{"key":"5171_CR60","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature13180","volume":"509","author":"DC Brady","year":"2014","unstructured":"Brady DC, Crowe MS, Turski ML et al (2014) Copper is required for oncogenic BRAF signalling and tumorigenesis. Nature 509:492\u2013496. https:\/\/doi.org\/10.1038\/nature13180","journal-title":"Nature"},{"key":"5171_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11050659","author":"S Baldari","year":"2019","unstructured":"Baldari S, Di Rocco G, Heffern MC et al (2019) Effects of copper chelation on BRAFV600E positive colon carcinoma cells. Cancers. https:\/\/doi.org\/10.3390\/cancers11050659","journal-title":"Cancers"},{"key":"5171_CR62","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1097\/00005537-200104000-00024","volume":"111","author":"C Cox","year":"2001","unstructured":"Cox C, Teknos TN, Barrios M et al (2001) The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma. Laryngoscope 111:696\u2013701. https:\/\/doi.org\/10.1097\/00005537-200104000-00024","journal-title":"Laryngoscope"},{"key":"5171_CR63","doi-asserted-by":"publisher","first-page":"6240","DOI":"10.1158\/0008-5472.Can-16-1190","volume":"77","author":"DC Brady","year":"2017","unstructured":"Brady DC, Crowe MS, Greenberg DN, Counter CM (2017) Copper chelation inhibits BRAF(V600E)-driven melanomagenesis and counters resistance to BRAF(V600E) and MEK1\/2 inhibitors. Cancer Res 77:6240\u20136252. https:\/\/doi.org\/10.1158\/0008-5472.Can-16-1190","journal-title":"Cancer Res"}],"container-title":["Biological Trace Element Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-026-05171-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12011-026-05171-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-026-05171-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:38:28Z","timestamp":1785825508000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12011-026-05171-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":63,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["5171"],"URL":"https:\/\/doi.org\/10.1007\/s12011-026-05171-w","relation":{},"ISSN":["1559-0720"],"issn-type":[{"value":"1559-0720","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors confirm their consent to publish this manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}